RIVUS PHARMACEUTICALS, INC.

Profile

Company Names

RIVUS PHARMACEUTICALS, INC.

Addresses

501 LOCUST AVENUE, SUITE 301, CHARLOTTESVILLE, VA 22902

706B FOREST STREET, CHARLOTTESVILLE, VA 22903

Phone Numbers

703-456-8000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$223,479,132.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-01-07 
$56,979,133.00 
$56,979,133.00 
$0.00 
Equity 
3
2024-08-09 
$66,000,000.00 
$66,000,000.00 
$0.00 
Equity 
2
2022-08-19 
$65,999,999.00 
$65,999,999.00 
$0.00 
Equity 
1
2019-03-26 
$34,500,000.00 
$35,000,532.00 
$500,532.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALLEN 
 
CUNNINGHAM 
EXECUTIVE OFFICER, DIRECTOR
RIVUS PHARMACEUTICALS, INC.
JAYSON 
 
DALLAS 
EXECUTIVE OFFICER, DIRECTOR
RIVUS PHARMACEUTICALS, INC.   |  GALECTO, INC.   |  FAETH THERAPEUTICS, INC.
FRANCESCO 
 
DE RUBERTIS 
DIRECTOR
NORMOXYS INC   |  NORMOXYS, INC.   |  VERSARTIS, INC.   |  MINERVA NEUROSCIENCES, INC.   |  MEDICXI GROWTH I LP   |  MEDICXI III LP   |  MEDICXI SECONDARY I LP   |  RIVUS PHARMACEUTICALS, INC.
DEREK 
 
DIROCCO 
DIRECTOR
WEREWOLF THERAPEUTICS, INC.   |  DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC   |  ACRIVON THERAPEUTICS, INC.   |  MINERALYS THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.   |  EVOMMUNE, INC.   |  BAMBUSA THERAPEUTICS, INC.   |  STIPPLE BIO, INC.
PATRICK 
 
ENRIGHT 
DIRECTOR
XANODYNE PHARMACEUTICALS INC   |  CARDIODX INC   |  LONGITUDE VENTURE PARTNERS II, L.P.   |  INFACARE PHARMACEUTICAL CORP   |  ESPERION THERAPEUTICS, INC.   |  ALLERGEN RESEARCH CORP   |  SUTROVAX, INC.   |  ORBUS THERAPEUTICS, INC.   |  LONGITUDE VENTURE PARTNERS III, L.P.   |  ROCK STARR LLC   |  ROCKPOINT LLC   |  APTINYX INC.   |  CURASEN THERAPEUTICS, INC.   |  STICHTING ADMINISTRATIEKANTOOR SYNCREON   |  VERA THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.   |  LONGITUDE VENTURE PARTNERS V, L.P.   |  LONGITUDE PRIME FUND II, L.P.   |  BIOAGE LABS, INC.   |  VERADERMICS, INC   |  LONGITUDE 103.8 EAST, L.P.   |  INFINANT HEALTH, INC.
NANCY 
 
HARGREAVES 
EXECUTIVE OFFICER
IONETIX CORP   |  RIVUS PHARMACEUTICALS, INC.
SHAHARYAR 
 
KHAN 
EXECUTIVE OFFICER, DIRECTOR
RIVUS PHARMACEUTICALS, INC.
ERIN 
 
LAVELLE 
DIRECTOR
ELIEM THERAPEUTICS, INC.   |  AVICEDA THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.
TOM 
 
O-NEIL 
EXECUTIVE OFFICER
RIVUS PHARMACEUTICALS, INC.
ROBERT 
 
SCHOTT 
EXECUTIVE OFFICER
RIVUS PHARMACEUTICALS, INC.
IAN 
 
SMITH 
DIRECTOR
CARGURUS LLC   |  CROSSHAIR EXPLORATION + MINING CORP   |  YELLOWHEAD MINING INC.   |  MAX RESOURCE CORP.   |  FUNKY EYES INTERNATIONAL, INC.   |  XAPO HOLDINGS LTD   |  CATHEDRAL LAKE II, LTD.   |  CATHEDRAL LAKE III, LTD.   |  CATHEDRAL LAKE CLO 2013, LTD.   |  FOODTRUCKR, LLC   |  AURORA INNOVATION, INC.   |  CARGURUS, INC.   |  VIACYTE INC.   |  SANATANA RESOURCES INC   |  SOLID BIOSCIENCES INC.   |  AURORA INNOVATION, INC.   |  ODYSSEY THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.
RICK 
 
WINNINGHAM 
DIRECTOR
RIVUS PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-01-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-01-07 
2024-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-09 
2024-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-19 
2021-10-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#